- Home
- WWW vs IRON Comparison
WWW vs IRON Comparison
Compare WWW & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- IRON
- Stock Information
- Founded
- WWW 1883
- IRON 2017
- Country
- WWW United States
- IRON United States
- Employees
- WWW N/A
- IRON N/A
- Industry
- WWW Shoe Manufacturing
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- IRON Health Care
- Exchange
- WWW Nasdaq
- IRON Nasdaq
- Market Cap
- WWW 1.9B
- IRON 1.9B
- IPO Year
- WWW N/A
- IRON N/A
- Fundamental
- Price
- WWW $22.80
- IRON $58.25
- Analyst Decision
- WWW Strong Buy
- IRON Strong Buy
- Analyst Count
- WWW 8
- IRON 10
- Target Price
- WWW $18.63
- IRON $73.70
- AVG Volume (30 Days)
- WWW 1.3M
- IRON 267.1K
- Earning Date
- WWW 02-19-2025
- IRON 11-12-2024
- Dividend Yield
- WWW 1.75%
- IRON N/A
- EPS Growth
- WWW N/A
- IRON N/A
- EPS
- WWW N/A
- IRON N/A
- Revenue
- WWW $1,787,000,000.00
- IRON N/A
- Revenue This Year
- WWW N/A
- IRON N/A
- Revenue Next Year
- WWW $6.76
- IRON N/A
- P/E Ratio
- WWW N/A
- IRON N/A
- Revenue Growth
- WWW N/A
- IRON N/A
- 52 Week Low
- WWW $7.99
- IRON $25.60
- 52 Week High
- WWW $24.64
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- WWW 52.56
- IRON 40.61
- Support Level
- WWW $22.51
- IRON $57.09
- Resistance Level
- WWW $23.54
- IRON $61.08
- Average True Range (ATR)
- WWW 0.72
- IRON 2.83
- MACD
- WWW -0.04
- IRON -0.58
- Stochastic Oscillator
- WWW 59.12
- IRON 14.04
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Lifestyle Group and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.